Beta-glucans in advanced CKD: role in endotoxaemia and inflammation.
C-Reactive Protein
/ analysis
Correlation of Data
Endotoxins
/ blood
Female
Humans
Inflammation
/ blood
Interleukin-6
/ blood
Invasive Fungal Infections
/ etiology
Kidney Failure, Chronic
/ blood
Male
Middle Aged
Patient Acuity
Peritoneal Dialysis
/ adverse effects
Renal Dialysis
/ adverse effects
Risk Assessment
/ methods
Severity of Illness Index
Tumor Necrosis Factor-alpha
/ blood
beta-Glucans
/ blood
(1–3)-β-D glucan
Dialysis
Endotoxin
Inflammation
Journal
BMC nephrology
ISSN: 1471-2369
Titre abrégé: BMC Nephrol
Pays: England
ID NLM: 100967793
Informations de publication
Date de publication:
06 04 2020
06 04 2020
Historique:
received:
20
11
2019
accepted:
23
03
2020
entrez:
8
4
2020
pubmed:
8
4
2020
medline:
8
9
2021
Statut:
epublish
Résumé
(1-3)-β-D glucans (BG) are cellular components of yeasts and fungi. Elevated blood levels may be an adjunct in diagnosing invasive fungal infection, though can be high in dialysis patients without fungaemia. BG can also induce false positive signals in endotoxin detection assays (Limulus Amoebocyte Lysate [LAL] assay). We explored the relationship between BG levels, renal impairment, endotoxaemia and inflammation. We measured serum BG levels, markers of inflammation and blood endotoxin levels in 20 controls, 20 with stages 1-3 chronic kidney disease (CKD), 20 with stages 4-5 CKD, 15 on peritoneal dialysis (PD) and 60 on haemodialysis (HD). Another 30 patients were studied before and after HD initiation. BG levels increased with advancing CKD, being highest in HD patients, 22% of whom had elevated levels (> 80 pg/ml). Levels increased significantly following HD initiation. Levels also correlated positively with CRP, TNFα, IL-6 levels, independently of CKD stage. Blood endotoxin was detectable by LAL assays in 10-53% of the CKD cohort, being most prevalent in the HD group, and correlating positively with BG levels. Adding BG blocking agent to the assay reduced endotoxin detection confining it to only 5% of HD patients. Levels of inflammatory markers were higher in those with detectable endotoxin - whether false- or true positives. BG levels increased with decreasing renal function, being highest in dialysis patients. High BG levels were associated with false positive blood endotoxin signals, and with markers of inflammation, independently of CKD stage. The cause for high BG levels is unknown but could reflect increased gut permeability and altered mononuclear phagocytic system function.
Sections du résumé
BACKGROUND/AIMS
(1-3)-β-D glucans (BG) are cellular components of yeasts and fungi. Elevated blood levels may be an adjunct in diagnosing invasive fungal infection, though can be high in dialysis patients without fungaemia. BG can also induce false positive signals in endotoxin detection assays (Limulus Amoebocyte Lysate [LAL] assay). We explored the relationship between BG levels, renal impairment, endotoxaemia and inflammation.
METHODS
We measured serum BG levels, markers of inflammation and blood endotoxin levels in 20 controls, 20 with stages 1-3 chronic kidney disease (CKD), 20 with stages 4-5 CKD, 15 on peritoneal dialysis (PD) and 60 on haemodialysis (HD). Another 30 patients were studied before and after HD initiation.
RESULTS
BG levels increased with advancing CKD, being highest in HD patients, 22% of whom had elevated levels (> 80 pg/ml). Levels increased significantly following HD initiation. Levels also correlated positively with CRP, TNFα, IL-6 levels, independently of CKD stage. Blood endotoxin was detectable by LAL assays in 10-53% of the CKD cohort, being most prevalent in the HD group, and correlating positively with BG levels. Adding BG blocking agent to the assay reduced endotoxin detection confining it to only 5% of HD patients. Levels of inflammatory markers were higher in those with detectable endotoxin - whether false- or true positives.
CONCLUSION
BG levels increased with decreasing renal function, being highest in dialysis patients. High BG levels were associated with false positive blood endotoxin signals, and with markers of inflammation, independently of CKD stage. The cause for high BG levels is unknown but could reflect increased gut permeability and altered mononuclear phagocytic system function.
Identifiants
pubmed: 32252666
doi: 10.1186/s12882-020-01779-9
pii: 10.1186/s12882-020-01779-9
pmc: PMC7137517
doi:
Substances chimiques
Endotoxins
0
IL6 protein, human
0
Interleukin-6
0
Tumor Necrosis Factor-alpha
0
beta-Glucans
0
C-Reactive Protein
9007-41-4
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
118Références
Clin Infect Dis. 2004 Jul 15;39(2):199-205
pubmed: 15307029
Perit Dial Int. 2018 Sep-Oct;38(5):381-384
pubmed: 30185481
Front Immunol. 2018 Apr 16;9:673
pubmed: 29755450
Biomed Res Int. 2017;2017:5765417
pubmed: 28194419
Semin Dial. 2015 Jan-Feb;28(1):59-67
pubmed: 25040340
J Clin Invest. 2017 Jun 30;127(7):2829-2841
pubmed: 28530644
J Infect. 2017 Jan;74(1):72-80
pubmed: 27717781
J Clin Microbiol. 2014 Jul;52(7):2328-33
pubmed: 24740084
Kidney Int. 2007 Nov;72(9):1138-48
pubmed: 17728708
Nephron Clin Pract. 2014;128(1-2):141-6
pubmed: 25401768
Intensive Care Med. 2000;26 Suppl 1:S51-6
pubmed: 10786959
Mediators Inflamm. 1997;6(4):279-83
pubmed: 18472859
J Inflamm (Lond). 2016 Jul 30;13:24
pubmed: 27478413
Compr Physiol. 2013 Apr;3(2):785-97
pubmed: 23720329
J Microbiol Immunol Infect. 2015 Aug;48(4):351-61
pubmed: 25081986
Mycopathologia. 2013 Feb;175(1-2):33-41
pubmed: 22945270
J Clin Pathol. 2015 Jan;68(1):73-8
pubmed: 25378540
Int J Mol Sci. 2017 Sep 05;18(9):
pubmed: 28872611
Nephrol Dial Transplant. 2006 Oct;21(10):2788-94
pubmed: 16861246
Nephrol Dial Transplant. 2007 Jan;22(1):128-38
pubmed: 17005525
Shock. 2016 Nov;46(5):506-518
pubmed: 27172153
J Pharmacobiodyn. 1991 Jan;14(1):9-19
pubmed: 1907324
Appl Environ Microbiol. 1984 Dec;48(6):1189-96
pubmed: 6517586
PLoS One. 2016 Oct 20;11(10):e0164978
pubmed: 27764208
J Immunol Methods. 2015 Jun;421:44-53
pubmed: 25595554
Nephron. 2001 Sep;89(1):15-9
pubmed: 11528226
J Innate Immun. 2018;10(3):189-201
pubmed: 29393221
Nephrology (Carlton). 2012 Nov;17(8):733-8
pubmed: 22817644
FEMS Immunol Med Microbiol. 1996 Sep;15(2-3):93-100
pubmed: 8880133
Kidney Int. 2001 Jul;60(1):319-23
pubmed: 11422767
Clin J Am Soc Nephrol. 2008 Sep;3(5):1526-33
pubmed: 18701615
Am J Nephrol. 2012;36(5):438-43
pubmed: 23128155
J Clin Microbiol. 2013 Nov;51(11):3478-83
pubmed: 23850953
Antimicrob Agents Chemother. 2008 Nov;52(11):4121-9
pubmed: 18779361
J Biochem Biophys Methods. 1991 Feb-Mar;22(2):93-100
pubmed: 2061565
Mycoses. 2015 Jan;58(1):4-9
pubmed: 25339221